Shenzhen, China, 2 November 2021 — Shanghai MicroPort MedBot (Group) Co., Ltd. (MicroPort® MedBot) recently held a signing ceremony to mark the strategic cooperation agreement with South China Hospital affiliated to Shenzhen University and a project initiation meeting for a clinical research program of Toumai® Laparoscopic Surgical Robot.
At the event, MicroPort® MedBot and South China Hospital signed a framework agreement on strategic cooperation, under which the two parties will pool their resources to jointly promote the establishment of a joint R&D laboratory. This collaboration will advance the technological innovation on robotic medicine and support the translation of research findings into clinical practices. Innovative medical robots will be quickly verified, iterated, and improved in practical applications thanks to collaboration between hospitals, industries, universities, and research institutes, further contributing to the rapid development of medical robotics with independent intellectual property rights.
At the ceremony, Mr. Song Wu, President of South China Hospital affiliated to Shenzhen University, and Mr. Yu Liu, Chief Commercial Officer of MicroPort® MedBot delivered speeches outlining the upcoming areas of cooperation. They expressed their hopes for the strategic collaboration and their wishes for the complete success of the partnership.
Mr. Yu Liu stated, "This is the first time that MicroPort® MedBot has partnered with a public hospital in Shenzhen. MicroPort® MedBot will work with South China Hospital to promote technological research and application development of minimally invasive robotic surgery, and conduct exploratory clinical treatment research within regulatory boundaries using multidisciplinary robotics, including endoscopic surgical instrument control systems and orthopedic surgery navigation and positioning systems. ”
President Song Wu noted, "It is one of the priorities of South China Hospital to build a pilot for medical robots. As the next step, South China Hospital will concentrate on strategizing and promoting innovation development. Guided by clinical solutions, we will actively carry out medical innovation, strengthen medical-industrial-academic-research cooperation for science and innovation through interdisciplinary cooperation, and promote the commercialization of medical innovations. It is our hope to promote high-level and high-quality development of the hospital through technology transformation and innovation. ”
About MicroPort® MedBot
Shanghai MicroPort MedBot (Group) Co., Ltd. (02252.HK, MicroPort® MedBot), a robotics-specialized subsidiary of MicroPort Scientific Corporation (00853.HK, MicroPort®), commenced its development for laparoscopic surgery robots in 2014 as an internal incubation project of MicroPort®. By integrating the cutting-edge research and robot ontology, control algorithms, electrical engineering, image-based navigation and precision imaging, MicroPort® MedBot provide comprehensive surgical solutions to prolong and reshape the lives of patients.